Results 221 to 230 of about 52,144 (318)

Tolerance induction for EGFR TKI hypersensitivity in lung cancer: Case report and review. [PDF]

J Allergy Clin Immunol Glob
Haraguchi Hashiguchi M, Adachi T, Asaoka M, Ito T, Kaburagi S, Kagyo J, Okata-Karigane U, Takahashi C, Tahara U, Yoneda S, Masaki K, Fukunaga K.   +11 more
europepmc   +1 more source

Efficacy and safety of using premedication with simethicone/Pronase during upper gastrointestinal endoscopy examination with sedation: A single center, prospective, single blinded, randomized controlled trial

Digestive Endoscopy, 2018
Ling-Ye Zhang, Wenyan Li, M. Ji, Fu K Liu, Guangyong Chen, Shanshan Wu, Q. Hao, Huihong Zhai, Shutian Zhang   +8 more
semanticscholar   +1 more source

Ondasetron as Premedication for Unsedated Upper Digestive Endoscopy: A Cross-Sectional Study Assessing Tolerance and Acceptability. [PDF]

Health Sci Rep
Murhi EB, Iranga RB, Lembembu C, Shindano TA.   +3 more
europepmc   +1 more source

Implementation and Evaluation of an Alternative Electronic Health Record Tool for Ordering Blood Products in Pediatric Oncology and Stem Cell Transplantation: Mixed Methods Analysis. [PDF]

JMIR Med Inform
Sarna A, Finkelstein A, Malcolmson C, Potashner R, Pitch N, Forestieri A, Cooper M, Feng Y, Patel A, Schechter T, Jessa K, Sung L, Yan AP.   +12 more
europepmc   +1 more source

Safety of intravenous neridronate in pediatric patients: insights from the monocentric retrospective NAPOLEON cohort. [PDF]

Ther Adv Musculoskelet Dis
Costi S, Amati A, Di Taranto R, Baldo F, Crotti C, Ricci M, Giani T, Gattinara MV, Varenna M, Caporali R, Chighizola CB, Marino A.   +11 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Immediate and delayed hypersensitivity to biologicals in children-A practical approach: An EAACI task force report. [PDF]

Pediatr Allergy Immunol
Mori F, Atanaskovic-Markovic M, Barbaud A, Bavbek S, Caubet JC, de Las Vecillas L, Giovannini M, Khaleva E, Labella M, Moral L, Riggioni C, Sabato V, Tsabouri S, Arasi S.   +13 more
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Elranatamab: Mechanism of Action, Clinical, and Translational Science. [PDF]

Clin Transl Sci
Elmeliegy M, Viqueira A, Vandendries E, Soltantabar P, Lon HK, Poels K, Shtylla B, Irby D, Bompiani-Myers K, O'Brien T, Hibma J.   +10 more
europepmc   +1 more source

Reinitiating ocrelizumab with a full 600 mg dose after extended treatment interruption: No increased risk of infusion-related reactions. [PDF]

Mult Scler J Exp Transl Clin
Schoof LG, Hogenboom L, van Kempen ZL, Killestein J, van Oosten BW, Strijbis EM.   +5 more
europepmc   +1 more source